Application Type
National
Application SubType
(10) Registration Number and Date
10202400829T
Status
ACTIVE ( Other event occurred)
(180) Expiration Date
(20) Filing Number and Date
SG 10202400829T 2023.12.31
(40) Publication Number and Date
(85) National Entry Date
(30) Priority Details
US
US62/961,141
2019.12.29
US63/136,599
2020.12.27
(51) IPC Classes
(71/73) Applicant
(72) Inventor
(74) Representative
(54) Title
(57) Abstract
(EN) BIASED IL2 MUTEINS METHODS AND COMPOSITIONS ABSTRACT The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease. [FIG. 1] - 160 -
(58) Citations
License Details
(98) Annuity Details
| Year | Validity Start | Validity End | Payment |
|---|
